Labcorp Holdings Inc. (LH) stock
LHNYSEServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 11/3016% above fair value
$368.24−4.22 (-1.13%)
Close on Nov 17, 2026Market cap $29.90BP/E 30.2Yield 0.78%
Labcorp operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Labcorp's operating income for the twelve months ending Sep 30, 2026 was $1.50B, up 12.6% year over year. For fiscal 2025 it was $1.38B, up 27.4% from the year before. Over ten years it grew 3.3% a year on average. The highest annual figure on record is $3.05B in fiscal 2021.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.38B | +27.4% |
| FY2024 | Dec 31, 2024 | $1.09B | +49.8% |
| FY2023 | Dec 31, 2023 | $725.60M | -49.5% |
| FY2022 | Dec 31, 2022 | $1.44B | -52.9% |
| FY2021 | Dec 31, 2021 | $3.05B | +24.7% |
| FY2020 | Dec 31, 2020 | $2.45B | +83.8% |
| FY2019 | Dec 31, 2019 | $1.33B | +0.3% |
| FY2018 | Dec 31, 2018 | $1.33B | +1.6% |
| FY2017 | Dec 31, 2017 | $1.31B | +2.7% |
| FY2016 | Dec 31, 2016 | $1.27B | +27.5% |
| FY2015 | Dec 31, 2015 | $996.80M | +9.5% |
| FY2014 | Dec 31, 2014 | $910.40M | -8.1% |
| FY2013 | Dec 31, 2013 | $990.90M | -3.2% |
| FY2012 | Dec 31, 2012 | $1.02B | +7.9% |
| FY2011 | Dec 31, 2011 | $948.40M | -3.1% |
| FY2010 | Dec 31, 2010 | $978.80M | +4.6% |
| FY2009 | Dec 31, 2009 | $935.90M | +11.0% |
| FY2008 | Dec 31, 2008 | $842.90M | +8.5% |
| FY2007 | Dec 31, 2007 | $777.00M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $402.10M | +1.4% |
| Q2 FY2026 | Jun 30, 2026 | $451.60M | +14.5% |
| Q1 FY2026 | Mar 31, 2026 | $380.80M | +16.8% |
| Q4 FY2025 | Dec 31, 2025 | $267.60M | +23.6% |
| Q3 FY2025 | Sep 30, 2025 | $396.60M | +56.1% |
| Q2 FY2025 | Jun 30, 2025 | $394.50M | +33.8% |
| Q1 FY2025 | Mar 31, 2025 | $326.00M | +1.5% |
| Q4 FY2024 | Dec 31, 2024 | $216.50M | – |
| Q3 FY2024 | Sep 30, 2024 | $254.10M | +0.7% |
| Q2 FY2024 | Jun 30, 2024 | $294.80M | +10.7% |
| Q1 FY2024 | Mar 31, 2024 | $321.30M | -2.6% |
| Q4 FY2023 | Dec 31, 2023 | -$122.80M | -530.9% |
| Q3 FY2023 | Sep 30, 2023 | $252.30M | -32.5% |
| Q2 FY2023 | Jun 30, 2023 | $266.30M | -37.9% |
| Q1 FY2023 | Mar 31, 2023 | $329.80M | -52.1% |
| Q4 FY2022 | Dec 31, 2022 | $28.50M | -94.5% |
| Q3 FY2022 | Sep 30, 2022 | $374.00M | -51.2% |
| Q2 FY2022 | Jun 30, 2022 | $428.80M | -39.1% |
| Q1 FY2022 | Mar 31, 2022 | $687.90M | -35.0% |
| Q4 FY2021 | Dec 31, 2021 | $519.70M | -59.8% |
| Q3 FY2021 | Sep 30, 2021 | $766.90M | -26.8% |
| Q2 FY2021 | Jun 30, 2021 | $704.10M | +136.5% |
| Q1 FY2021 | Mar 31, 2021 | $1.06B | – |
| Q4 FY2020 | Dec 31, 2020 | $1.29B | +284.4% |
| Q3 FY2020 | Sep 30, 2020 | $1.05B | +208.1% |
| Q2 FY2020 | Jun 30, 2020 | $297.70M | -11.3% |
| Q1 FY2020 | Mar 31, 2020 | -$192.60M | -160.5% |
| Q4 FY2019 | Dec 31, 2019 | $336.40M | +9.3% |
| Q3 FY2019 | Sep 30, 2019 | $339.90M | -1.0% |
| Q2 FY2019 | Jun 30, 2019 | $335.70M | -9.1% |
| Q1 FY2019 | Mar 31, 2019 | $318.20M | +4.2% |
| Q4 FY2018 | Dec 31, 2018 | $307.70M | -6.9% |
| Q3 FY2018 | Sep 30, 2018 | $343.40M | +5.1% |
| Q2 FY2018 | Jun 30, 2018 | $369.20M | +11.9% |
| Q1 FY2018 | Mar 31, 2018 | $305.40M | -4.0% |
| Q4 FY2017 | Dec 31, 2017 | $330.60M | +17.4% |
| Q3 FY2017 | Sep 30, 2017 | $326.70M | – |
| Q2 FY2017 | Jun 30, 2017 | $329.80M | – |
| Q1 FY2017 | Mar 31, 2017 | $318.10M | – |
| Q4 FY2016 | Dec 31, 2016 | $281.60M | – |
See a number that looks wrong?